Nanomedicine in the diagnosis and therapy of neurodegenerative disorders
- 1 August 2007
- journal article
- review article
- Published by Elsevier in Progress in Polymer Science
- Vol. 32 (8-9) , 1054-1082
- https://doi.org/10.1016/j.progpolymsci.2007.05.014
Abstract
No abstract availableKeywords
This publication has 346 references indexed in Scilit:
- Genetically engineered human neural stem cells for brain repair in neurological diseasesBrain & Development, 2007
- TAT-BH4 counteracts Aβ toxicity on capillary endotheliumFEBS Letters, 2007
- A novel therapeutic approach to 6-OHDA-induced Parkinson’s disease in rats via supplementation of PTD-conjugated tyrosine hydroxylaseBiochemical and Biophysical Research Communications, 2006
- Mechanisms of the Blood–Brain Barrier Disruption in HIV-1 InfectionCellular and Molecular Neurobiology, 2005
- Raft and cytoskeleton associations of an ABC transporter: P‐glycoproteinCytometry Part A, 2004
- Passage of peptides across the blood-brain barrier: Pathophysiological perspectivesLife Sciences, 1996
- Water‐soluble fatty acid derivatives as acylating agents for reversible lipidization of polypeptidesFEBS Letters, 1995
- Fate of mouse macrophages radiolabelled with PKH-95 and injected intravenouslyNuclear Medicine and Biology, 1995
- Fatty Acid Acylation of RNase A Using Reversed Micelles as MicroreactorsBiochemical and Biophysical Research Communications, 1993
- Liposome targeting to mouse brain: Mannose as a recognition markerBiochemical and Biophysical Research Communications, 1988